Biomerica BMRA
NASDAQ BMRA
$1.61 +0.02 (+1.58%)
As of: Aug 21, 2026 · 3:54 PM EDT

Biomerica (BMRA) Other Accumulated Expenses (2020)

Biomerica (BMRA) posted Other Accumulated Expenses of $6670.0 for Q2 2020.

Biomerica (BMRA) Other Accumulated Expenses (2020) Analysis & Trends

Biomerica has reported Other Accumulated Expenses for 1 years, with the latest figure at $6670.0 in Q2 2020.

  • Quarterly Other Accumulated Expenses changed N/A year-over-year to $6670.0 in Q2 2020, while the trailing twelve-month figure through May 2020 was $6670.0 (changed N/A YoY) and the FY2020 annual result came in at $6670.0, changed N/A from the prior year.
  • Other Accumulated Expenses was little changed at $6670.0 in Q2 2020 per BMRA's latest filing.
  • Over five years, Other Accumulated Expenses peaked at $6670.0 in Q2 2020 and troughed at $6670.0 in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn
10 Biomerica 4.85 Mn 3.51 Mn -44,000.00

Historic Data

Download Data
DateValue
May 31, 2020 6,670.00